Luminex Corp (NASDAQ:LMNX)
During the Trading Day
| 20.39 |  -0.39 / -1.88% |
Data as of 3:59pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 20.39 |  0.00 / 0.00% |
Volume: 3.7K |
Latest LMNX News | Press Releases
| Why GenMark Diagnostics Shares Slumped Jun 18 / MotleyFool.com | Why Luminex May Be About to Take Off Jun 07 / MotleyFool.com |
| Luminex Collaborates with NMTC - Analyst Blog Jun 14 / Zacks.com |
Today’s Trading
| Previous close | 20.78 |
| Today’s open | 20.75 |
| Day’s range | 20.26 - 20.75 |
| Volume | 103,006 |
| Average volume (3 months) | 185,771 |
| Market cap | $873.0M |
| Dividend yield | -- |
Data as of 3:59pm ET, 06/19/2013
Growth & Valuation
| Earnings growth (last year) | -11.76% |
| Earnings growth (this year) | +21.93% |
| Earnings growth (next 5 years) | +24.00% |
| Revenue growth (last year) | +9.90% |
| P/E ratio | 127.4 |
| Price/Sales | 3.39 |
| Price/Book | 3.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ABMDAbiomed Inc | +0.07 | +0.32% |
| EXASExact Sciences Corp | +0.07 | +0.55% |
| TRNXTornier NV | -0.21 | -1.23% |
| NUVANuVasive Inc | +0.51 | +2.28% |
Data as of 3:59pm ET, 06/19/2013
Financials
| Next reporting date | August 8, 2013 |
| EPS forecast (this quarter) | $0.11 |
| Annual revenue (last year) | $202.6M |
| Annual profit (last year) | $12.4M |
| Net profit margin | 6.12% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Patrick J. Balthrop, Sr., MBA |
Senior Vice President- Operations Michael F. Pintek |
Corporate headquarters Austin, Texas |
Forecasts
